India vs Laos: Cost drugs extensive resistant tb
India
1,203
in 2024
Laos
1,250
in 2024
India rank
39th
Laos rank
37th
Cost drugs extensive resistant tb over time
- India
- Laos
How they compare
Laos currently reports 1,250 against 1,203 in India, a difference of 47.
The two have swapped places 1 time across 7 shared years of data; in 2018 it was India ahead.
India ranks 39th and Laos ranks 37th of 56 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5,000 | 1,250 | 3,750 | India |
| 2020s | 2,104 | 1,240 | 863.6 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cost drugs extensive resistant tb, India or Laos?
- Laos, at 1,250 against 1,203 in India as of 2024.
- What is the difference in cost drugs extensive resistant tb between India and Laos?
- 47, with Laos ahead.
- How many years of comparable data are there for India and Laos?
- 7 years are reported by both, from 2018 to 2024.
- How do India and Laos rank globally for cost drugs extensive resistant tb?
- India ranks 39th and Laos ranks 37th of 56 countries.
- Where does this data come from?
- Our World in Data, published as Cost drugs extensive resistant tb. Statizoid refreshes it automatically from the source and publishes the full history for both places.